ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway

Yixuan Wu, Feng Wang|Journal of Nanobiotechnology|2024

Cited by 6